IL-6 is a predictive biomarker for stroke associated infection and future mortality in the elderly after an ischemic stroke
Authors:
- Joseph KwanJKJoseph Kwan
- Gill HorsfieldGHGill Horsfield
- Timothy BryantTBTimothy Bryant
- Mary Gawne-CainMGMary Gawne-Cain
- Giles DurwardGDGiles Durward
- Christopher D. ByrneCBChristopher D. Byrne
- Nicola A. EnglystNENicola A. Englyst
- 1 September 2013
- journal article
- Published by Elsevier in Experimental Gerontology
- Vol. 48 (9) , 960-965
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Protection from brain damage and bacterial infection in murine stroke by the novel caspase-inhibitor Q-VD-OPHExperimental Neurology, 2007
- Infection After Acute Ischemic StrokeStroke, 2007
- Catecholamines, infection, and death in acute ischemic strokeJournal of the Neurological Sciences, 2007
- Interleukin 10, monocytes and increased risk of early infection in ischaemic strokeJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Inflammatory Markers and Onset of Cardiovascular EventsCirculation, 2003
- Interleukin-6 Induces Monocyte Chemotactic Protein-1 in Peripheral Blood Mononuclear Cells and in the U937 Cell LineBlood, 1998
- Complications After Acute StrokeStroke, 1996
- Evolution of Neuropathologic Abnormalities Associated with Blood-Brain Barrier Breakdown in Transgenic Mice Expressing lnterleukin-6 in AstrocytesJournal of Neuropathology & Experimental Neurology, 1995
- Classification and natural history of clinically identifiable subtypes of cerebral infarctionThe Lancet, 1991
- Measurements of acute cerebral infarction: a clinical examination scale.Stroke, 1989